We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Image of Jonathan Druge

Jonathan Druge

Global Product Manager, Miltenyi Biotec

Jonathan Druge joined Miltenyi Biotec in 2019 to pursue his doctoral studies in immuno-oncology, as part of the network “Manufacturing tumor-reactive Natural Killer cells” (MATURE-NK) project, a European Union-funded consortium run by the Marie Skłodowska Curie Action program. While under the academic supervision of Ulrike Köhl and Adelheid Cerwenka, two leading experts in the field of NK cells, Jonathan focused on developing next-generation CAR NK cells. After the successful completion of the experimental part of his PhD, he joined the Miltenyi Biotec Marketing Department in 2022, specializing in research applications related to cell and gene therapies in immuno-oncology.

Got a question for Jonathan Druge?

Get in touch using the contact form linked here and we’ll get back to you shortly